Literature DB >> 22674578

Structural insights into the catalytic active site and activity of human Nit2/ω-amidase: kinetic assay and molecular dynamics simulation.

Chin-Hsiang Chien1, Quan-Ze Gao, Arthur J L Cooper, Jyun-Hong Lyu, Sheh-Yi Sheu.   

Abstract

Human nitrilase-like protein 2 (hNit2) is a putative tumor suppressor, recently identified as ω-amidase. hNit2/ω-amidase plays a crucial metabolic role by catalyzing the hydrolysis of α-ketoglutaramate (the α-keto analog of glutamine) and α-ketosuccinamate (the α-keto analog of asparagine), yielding α-ketoglutarate and oxaloacetate, respectively. Transamination between glutamine and α-keto-γ-methiolbutyrate closes the methionine salvage pathway. Thus, hNit2/ω-amidase links sulfur metabolism to the tricarboxylic acid cycle. To elucidate the catalytic specificity of hNit2/ω-amidase, we performed molecular dynamics simulations on the wild type enzyme and its mutants to investigate enzyme-substrate interactions. Binding free energies were computed to characterize factors contributing to the substrate specificity. The predictions resulting from these computations were verified by kinetic analyses and mutational studies. The activity of hNit2/ω-amidase was determined with α-ketoglutaramate and succinamate as substrates. We constructed three catalytic triad mutants (E43A, K112A, and C153A) and a mutant with a loop 116-128 deletion to validate the role of key residues and the 116-128 loop region in substrate binding and turnover. The molecular dynamics simulations successfully verified the experimental trends in the binding specificity of hNit2/ω-amidase toward various substrates. Our findings have revealed novel structural insights into the binding of substrates to hNit2/ω-amidase. A catalytic triad and the loop residues 116-128 of hNit2 play an essential role in supporting the stability of the enzyme-substrate complex, resulting in the generation of the catalytic products. These observations are predicted to be of benefit in the design of new inhibitors or activators for research involving cancer and hyperammonemic diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22674578      PMCID: PMC3406660          DOI: 10.1074/jbc.M111.259119

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Electrostatics of nanosystems: application to microtubules and the ribosome.

Authors:  N A Baker; D Sept; S Joseph; M J Holst; J A McCammon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

2.  Crystal structure of a putative CN hydrolase from yeast.

Authors:  Desigan Kumaran; Subramaniam Eswaramoorthy; Sue Ellen Gerchman; Helen Kycia; F William Studier; Subramanyam Swaminathan
Journal:  Proteins       Date:  2003-08-01

3.  Preparation of enzymatic reactions of the keto analogues of asparagine and glutamine.

Authors:  A MEISTER
Journal:  J Biol Chem       Date:  1953-02       Impact factor: 5.157

4.  Protein structure modeling with MODELLER.

Authors:  Narayanan Eswar; David Eramian; Ben Webb; Min-Yi Shen; Andrej Sali
Journal:  Methods Mol Biol       Date:  2008

5.  Rat liver -amidase. Kinetic evidence for an acyl-enzyme intermediate.

Authors:  L B Hersh
Journal:  Biochemistry       Date:  1972-06-06       Impact factor: 3.162

6.  Rat liver omega-amidase. Purification and properties.

Authors:  L B Hersh
Journal:  Biochemistry       Date:  1971-07-20       Impact factor: 3.162

Review 7.  The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes.

Authors:  Arnold J Levine; Anna M Puzio-Kuter
Journal:  Science       Date:  2010-12-03       Impact factor: 47.728

8.  Molecular identification of omega-amidase, the enzyme that is functionally coupled with glutamine transaminases, as the putative tumor suppressor Nit2.

Authors:  Stéphane Jaisson; Maria Veiga-da-Cunha; Emile Van Schaftingen
Journal:  Biochimie       Date:  2009-07-14       Impact factor: 4.079

9.  Functional proteomic and structural insights into molecular recognition in the nitrilase family enzymes.

Authors:  Katherine T Barglow; Kumar S Saikatendu; Michael H Bracey; Ruth Huey; Garrett M Morris; Arthur J Olson; Raymond C Stevens; Benjamin F Cravatt
Journal:  Biochemistry       Date:  2008-12-23       Impact factor: 3.162

Review 10.  Glutamine in neoplastic cells: focus on the expression and roles of glutaminases.

Authors:  Monika Szeliga; Marta Obara-Michlewska
Journal:  Neurochem Int       Date:  2009-02-07       Impact factor: 3.921

View more
  4 in total

1.  Biochemical and cellular analysis of human variants of the DYT1 dystonia protein, TorsinA/TOR1A.

Authors:  Jasmin Hettich; Scott D Ryan; Osmar Norberto de Souza; Luís Fernando Saraiva Macedo Timmers; Shelun Tsai; Nadia A Atai; Cintia C da Hora; Xuan Zhang; Rashmi Kothary; Erik Snapp; Maria Ericsson; Kathrin Grundmann; Xandra O Breakefield; Flávia C Nery
Journal:  Hum Mutat       Date:  2014-07-17       Impact factor: 4.878

Review 2.  α-Ketoglutaramate: an overlooked metabolite of glutamine and a biomarker for hepatic encephalopathy and inborn errors of the urea cycle.

Authors:  Arthur J L Cooper; Tomiko Kuhara
Journal:  Metab Brain Dis       Date:  2013-11-14       Impact factor: 3.584

3.  The mechanism of the amidases: mutating the glutamate adjacent to the catalytic triad inactivates the enzyme due to substrate mispositioning.

Authors:  Brandon W Weber; Serah W Kimani; Arvind Varsani; Donald A Cowan; Roger Hunter; Gerhard A Venter; James C Gumbart; B Trevor Sewell
Journal:  J Biol Chem       Date:  2013-08-14       Impact factor: 5.157

4.  Cyanide Hydratase Modification Using Computational Design and Docking Analysis for Improved Binding Affinity in Cyanide Detoxification.

Authors:  Narges Malmir; Najaf Allahyari Fard; Yamkela Mgwatyu; Lukhanyo Mekuto
Journal:  Molecules       Date:  2021-03-23       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.